お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
市場調査レポート
商品コード
949713

ウェアラブルインジェクター市場:タイプ、用途、エンドユーザー、地域別の市場分析、およびCOVID-19の影響(2027年までの予測)

Wearable Injectors Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type ; Application ; End User ; and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 184 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.37円
ウェアラブルインジェクター市場:タイプ、用途、エンドユーザー、地域別の市場分析、およびCOVID-19の影響(2027年までの予測)
出版日: 2020年06月19日
発行: The Insight Partners
ページ情報: 英文 184 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のウェアラブルインジェクター市場は、2019年に57億9,123万米ドルとなりました。同市場は、2020年から2027年の間に11.6%のCAGRで成長する見通しで、2027年には138億8,088万米ドルに達すると予測されています。

当レポートは世界のウェアラブルインジェクター市場について調査しており、市場の機会や動向、成長および抑制要因、タイプ・用途・エンドユーザー・地域別の市場分析、新型コロナウイルス感染症による市場への影響、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

第2章 要点

第3章 調査手法

第4章 市場情勢

  • 概観
  • PEST分析
  • 専門家の意見

第5章 市場力学

  • 市場成長要因
  • 市場抑制要因
  • 市場機会
  • 今後の動向
  • 影響分析

第6章 世界市場分析

  • 世界市場の収益予測と分析
  • 予測と分析:地域別
  • 主要企業の市場における位置づけ

第7章 市場分析:タイプ別

  • 概観
  • 市場シェア(2019&2027)
  • オンボディインジェクター
  • オフボディインジェクター

第8章 市場分析:用途別

  • 概観
  • 市場シェア(2019&2027)
  • 腫瘍
  • 糖尿病
  • 自己免疫疾患
  • 循環器疾患
  • その他

第9章 市場分析:エンドユーザー別

  • 概観
  • 市場シェア(2019&2027)
  • 在宅医療の設定
  • 病院・診療所
  • その他

第10章 市場分析:地域別

  • 北米
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ
  • 中南米

第11章 COVID-19パンデミックの影響

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第12章 競合情勢

  • 概観
  • 市場参入企業の成長戦略
  • 有機的開発
  • 無機的開発

第13章 企業プロファイル

  • BD
  • CeQur SA
  • Debiotech S.A.
  • E3D Elcam Drug Delivery Devices
  • Insulet Corporation
  • Gerresheimer AG
  • Tandem Diabetes Care Inc.
  • Zealand Pharma A/S
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG
  • Medtronic
  • Amgen, Inc.

第14章 付録

図表

List Of Tables

  • Table 1. North America Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 3. North America Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 4. US Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 5. US Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 6. US Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 7. Canada Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 8. Canada Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 9. Canada Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Mexico Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Mexico Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 12. Mexico Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Europe Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Europe Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 15. Europe Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Germany Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Germany Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 18. Germany Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 19. UK Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 20. UK Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 21. UK Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 22. France Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 23. France Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 24. France Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 25. Spain Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 26. Spain Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 27. Spain Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 28. Italy Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 29. Italy Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 30. Italy Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 31. Asia Pacific Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 32. Asia Pacific Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 33. Asia Pacific Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 34. China Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 35. China Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 36. China Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 37. Japan Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 38. Japan Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 39. Japan Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 40. India Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 41. India Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 42. India Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 43. South Korea Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 44. South Korea Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 45. South Korea Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 46. Australia Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 47. Australia Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 48. Australia Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 49. Middle East & Africa Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 50. Middle East & Africa Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 51. Middle East & Africa Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 52. UAE Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 53. UAE Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 54. UAE Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 55. Saudi Arabia Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 56. Saudi Arabia Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 57. Saudi Arabia Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 58. South Africa Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 59. South Africa Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 60. South Africa Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 61. South and Central America Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 62. South and Central America Wearable Injectors Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 63. South and Central America Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 64. Brazil Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 65. Brazil Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 66. Brazil Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 67. Argentina Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 68. Argentina Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
  • Table 69. Argentina Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 70. Organic Developments Done By Companies
  • Table 71. Inorganic Developments Done By Companies
  • Table 72. Glossary of Terms, Wearable Injectors Market

List Of Figures

  • Figure 1. Wearable Injectors Market Segmentation
  • Figure 2. Wearable Injectors Segmentation, By Region
  • Figure 3. Global Wearable Injectors Market Overview
  • Figure 4. On-body Injectors Segment Held Largest Share of Wearable Injectors Market
  • Figure 5. Asia Pacific to Show Remarkable Growth During Forecast Period
  • Figure 6. Wearable Injectors Market, by Geography (US$ Million)
  • Figure 7. Global Wearable Injectors Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Wearable Injectors Market, Industry Landscape
  • Figure 9. North America : PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East & Africa PEST Analysis
  • Figure 13. South & Central America PEST Analysis
  • Figure 14. Wearable Injectors Market Impact Analysis of Driver and Restraints
  • Figure 15. Global Wearable Injectors Market - Revenue Forecast and Analysis - 2019- 2027
  • Figure 16. Global Wearable Injectors Market - By Geography Forecast and Analysis - 2019- 2027
  • Figure 17. Market Positioning Of Key Players In Global Wearable Injectors Market
  • Figure 18. Wearable Injectors Market Share, by Type, 2019 and 2027 (%)
  • Figure 19. On-body injectors: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 20. Off-body injectors: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 21. Wearable Injectors Market Share, by Application, 2019 and 2027 (%)
  • Figure 22. Oncology: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 23. Diabetes: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 24. Autoimmune Disease: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 25. Cardiovascular Disease: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 26. Other Applications: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 27. Wearable Injectors Market Share, by End user, 2019 and 2027 (%)
  • Figure 28. Homecare Setting: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 29. Hospitals and Clinics: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 30. Other End Users: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 31. North America: Wearable Injectors Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 32. North America Wearable Injectors Market Revenue and Forecast to 2027 (USD Million)
  • Figure 33. North America: Wearable Injectors Market, by Country, 2019 & 2027 (%)
  • Figure 34. US: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 35. Canada: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 36. Canada Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Figure 37. Mexico: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 38. Europe: Wearable Injectors Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 39. Europe Wearable Injectors Market Revenue and Forecast to 2027 (USD Million)
  • Figure 40. Europe: Wearable Injectors Market, by Country, 2019 & 2027 (%)
  • Figure 41. Germany: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 42. UK: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 43. France: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 44. Spain: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 45. Italy: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 46. Asia Pacific: Wearable Injectors Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 47. Asia Pacific Wearable Injectors Market Revenue and Forecast to 2027 (USD Million)
  • Figure 48. Asia Pacific: Wearable Injectors Market, by Country, 2019 & 2027 (%)
  • Figure 49. China: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 50. Japan: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 51. India: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 52. South Korea: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 53. Australia: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 54. Middle East & Africa: Wearable Injectors Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 55. Middle East & Africa Wearable Injectors Market Revenue and Forecast to 2027 (USD Million)
  • Figure 56. Middle East & Africa: Wearable Injectors Market, by Country, 2018 & 2027 (%)
  • Figure 57. UAE: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 58. Saudi Arabia: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 59. South Africa: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 60. South and Central America: Wearable Injectors Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 61. South and Central America Wearable Injectors Market Revenue and Forecast to 2027 (USD Million)
  • Figure 62. South and Central America: Wearable Injectors Market, by Country, 2019 & 2027 (%)
  • Figure 63. Brazil: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 64. Argentina: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 65. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 66. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 67. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 68. Impact Of COVID-19 Pandemic in Rest of the World Countries Market
  • Figure 69. Growth Strategies Done by the Companies in the Market, (%)
目次
Product Code: TIPMD00002677

Title:
Wearable Injectors Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type (On-Body Injectors and Off-Body Injectors); Application (Diabetes, Oncology, Cardiovascular Diseases, Autoimmune Diseases, and Other Applications); End User (Hospitals and Clinics, Homecare Setting, and Other End Users); and Geography.

The wearable injectors market was valued at US$ 5,791.23 million in 2019 and is projected to reach US$ 13,880.88 million by 2027; it is expected to grow at a CAGR of 11.6% during 2020-2027.

Wearable injectors are drug delivery devices adhering to the body to deliver larger volumes of drugs subcutaneously. Several pharmaceutical and medical device companies have developed wearable injectors. The devices consist of a reservoir for medicine, a cannula for substance delivery to tissues, and a drive system to deliver the appropriate drug volume; it is loaded with adhesive to fix the device to the patients' skin. The growth of the wearable injector market is attributed to the increasing chronic disease prevalence, technological advancements and design development, and conventional drug delivery system limitations, among others. However, the lack of adoption in emerging countries limits the market growth. Further, the increasing demand for biologics is a significant opportunity for the global wearable injectors market players.

Lucrative Regional Wearable Injectors Markets

Market Insights

Technological Advancements and Design Development

Wearable injectors are rapidly gaining their prominence in the market owing to their capabilities in delivering a high volume of viscous formulations. The administration of pharmaceuticals via intravenous (IV) infusion is expensive in healthcare settings. Self-administration of subcutaneous injections is expected to save 30-70% of costs. Moreover, administration through conventional methods poses risks such as inaccurate dosage and needle stick injuries. The rise in the number of biologic drugs that are not suitable for oral administration has increased the adoption of wearable injection devices. Higher dosage volumes and viscous formulations of these drugs are further emphasizing the need for alternative injection methods such as wearable injectors. For instance, the enFuse wearable injector manufactured by Enable Injections is used for subcutaneous delivery of high-volume therapeutics outside a healthcare facility. The company has also introduced mobile monitoring and more significant volume capabilities to its high-volume wearable injectors.

A new category of wearable products has emerged, bridging the gap between functionality and cost while improving patient safety and quality of life. One such example is Stevanato Group's cartridge-based wearable device, currently under development, received Best Innovation in Drug Delivery Device award at Pharmapack Awards in 2019. The product includes a disposable, wearable pod, and reusable handheld controller that serves as the user interface and control unit for the pod. This is used for varied therapeutic areas, including diabetes, hormone therapies, pain management, and Alzheimer's disease treatment. Moreover, continuous development by leading players in upgrading the existing wearable injector portfolio is further driving the demand for wearable injectors. For instance, in February 2020, BD, a leading global medical technology company, completed a human clinical trial of the BD Libertas Wearable Injector. The award-winning injector is currently in development and is designed as a subcutaneous drug delivery system to deliver biologics with viscosities up to 50 cP in 2-5 mL and 5-10 mL configurations.

Products Insights

Based on type, the wearable injectors market is segmented into on-body injectors and off-body injectors. In 2019, the on-body injectors segment accounted for a larger share of the global wearable injectors market. On-body injectors ensure comfort and ease of use, confer water resistance and flexible dosing features, and facilitate automatic warming of refrigerated drugs. These benefits have led to the rise in demand for on-body injectors. Moreover, the market for off-body injectors is expected to grow at a faster pace during the forecast period, and the projected growth is attributed to the fact that these devices are free of the risks of skin fitting issues and allergic skin reactions.

End User Insights

Based on end user, the wearable injectors market is segmented into hospitals and clinics, homecare setting, and other end users. The homecare setting segment held the largest share in the global wearable injectors market in 2019. Growth of the market for this segment is attributed to expose to global trends, increasing chronic diseases prevalence, technological advancements and design development, and conventional drug delivery system limitations. For instance, the home care segment is anticipated to dominate the market due to the growing inclination toward self-administration of medicine and the rising preference of low-cost healthcare procedures. Also, the increasing demand for technologically developed drug delivery options to lowers the frequency of hospital visits and requires minimal expertise. Moreover, the ease of use, and ready availability and accessibility has also increased the adoption of wearable injectors among patients. Hence, this has increased the use of drug delivery systems in in-home care settings.

Strategic Insights

Collaborations and technology partnerships by the players operating in the market to bridge the demand-supply gap are anticipated to play a significant role in the growth of the wearable injectors market during the forecast period. Moreover, the growing number of accidents and trauma cases, and rising incidence of infectious diseases are predicted to accelerate market growth.

By Type

On-body Injectors

Off-body Injectors

By Application

Diabetes

Oncology

Cardiovascular Disease

Autoimmune Disease

Other Applications

By End User

Hospitals and Clinics

Homecare Setting

Other End User

By Geography

North America

US

Canada

Mexico

Europe

France

Germany

Italy

UK

Russia

Rest of Europe

Asia Pacific (APAC)

China

India

South Korea

Japan

Australia

Rest of Asia Pacific

Middle East and Africa (MEA)

South Africa

Saudi Arabia

UAE

Rest of Middle East and Africa

South and Central America (SCAM)

Brazil

Argentina

Rest of South America

Company Profiles

Amgen, Inc.

Medtronic

BD

Insulet Corporation

Gerresheimer AG (Sensile Medical)

West Pharmaceutical Services, Inc.

Ypsomed AG,

Tandem Diabetes Care, Inc.

Cequr SA

Debiotech S.A

E3D Elcam Drug Delivery Devices

Zealand Pharma A/S (Valeritas, Inc.)

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global wearable injectors market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global wearable injectors market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Wearable Injectors Market - By Type
    • 1.3.2 Global Wearable Injectors Market - By Application
    • 1.3.3 Global Wearable Injectors Market - By End User
    • 1.3.4 Global Wearable Injectors Market - By Geography

2. Wearable Injectors Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Wearable Injectors Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 Middle East & Africa- PEST Analysis
    • 4.2.5 South & Central America - PEST Analysis
  • 4.3 Expert Opinion

5. Wearable Injectors Market - Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Chronic Diseases Prevalence
    • 5.1.2 Technological Advancements and Design Development
    • 5.1.3 Conventional Drug Delivery System Limitations
  • 5.2 Market Restraints
    • 5.2.1 Lack of Adoption in Emerging Countries
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Demand for Biologics
  • 5.4 Future Trends
    • 5.4.1 Integration of Wearable Injectors During Early Drug Development
  • 5.5 Impact Analysis

6. Wearable Injectors Market - Global Analysis

  • 6.1 Global Wearable Injectors Market Revenue Forecast and Analysis
  • 6.2 Global Wearable Injectors Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Wearable Injectors Market- By Type

  • 7.1 Overview
  • 7.2 Wearable Injectors Market Share, by Type, 2019 and 2027 (%)
  • 7.4 On-body Injectors
    • 7.4.1 Overview
    • 7.4.2 On-body Injectors: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
  • 7.5 Off-body Injectors
    • 7.5.1 Overview
    • 7.5.2 Off-body Injectors: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)

8. Wearable Injectors Market- By Application

  • 8.1 Overview
  • 8.2 Wearable Injectors Market Share, by Application, 2019 and 2027 (%)
  • 8.4 Oncology
    • 8.4.1 Overview
    • 8.4.2 Oncology: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
  • 8.5 Diabetes
    • 8.5.1 Overview
    • 8.5.2 Diabetes: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
  • 8.6 Autoimmune Disease
    • 8.6.1 Overview
    • 8.6.2 Autoimmune Disease: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
  • 8.7 Cardiovascular Disease
    • 8.7.1 Overview
    • 8.7.2 Cardiovascular Disease: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
  • 8.8 Other Applications
    • 8.8.1 Overview
    • 8.8.2 Other Applications: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)

9. Wearable Injectors Market- By End User

  • 9.1 Overview
  • 9.2 Wearable Injectors Market Share, by End user, 2019 and 2027 (%)
  • 9.4 Homecare Setting
    • 9.4.1 Overview
    • 9.4.2 Homecare Setting: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
  • 9.5 Hospitals and Clinics
    • 9.5.1 Overview
    • 9.5.2 Hospitals and Clinics: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)
  • 9.6 Other End Users
    • 9.6.1 Overview
    • 9.6.2 Other End Users: Wearable Injectors Market Market- Revenue and Forecast to 2027 (USD Million)

10. Wearable Injectors Market - Geographic Analysis

  • 10.1 North America: Wearable Injectors Market
    • 10.1.1 Overview
    • 10.1.2 North America: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
    • 10.1.3 North America Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.1.4 North America Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
    • 10.1.5 North America Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.1.6 North America: Wearable Injectors Market, by Country, 2019 & 2027 (%)
    • 10.1.7 US: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 US: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 US Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.3 US Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.1.7.4 US Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.1.8 Canada: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.1 Canada: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.2 Canada Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.3 Canada Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.1.8.4 Canada Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.1.9 Mexico: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.1 Mexico: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.2 Mexico Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.3 Mexico Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.1.9.4 Mexico Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • 10.2 Europe: Wearable Injectors Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
    • 10.2.3 Europe Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.2.4 Europe Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
    • 10.2.5 Europe Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.2.6 Europe: Wearable Injectors Market, by Country, 2019 & 2027 (%)
    • 10.2.7 Germany: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.1 Germany: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.2 Germany Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.3 Germany Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.2.7.4 Germany Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.2.8 UK: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.1 UK: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.2 UK Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.3 UK Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.2.8.4 UK Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.2.9 France: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.1 France: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.2 France Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.3 France Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.2.9.4 France Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.2.10 Spain: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.1 Spain: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.2 Spain Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.3 Spain Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.2.10.4 Spain Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.2.11 Italy: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.1 Italy: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.2 Italy Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.3 Italy Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.2.11.4 Italy Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • 10.3 Asia Pacific: Wearable Injectors Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
    • 10.3.3 Asia Pacific Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.3.4 Asia Pacific Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
    • 10.3.5 Asia Pacific Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.3.6 Asia Pacific: Wearable Injectors Market, by Country, 2019 & 2027 (%)
    • 10.3.7 China: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.1 China: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.2 China Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.3 China Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.3.7.4 China Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.3.8 Japan: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.1 Japan: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.2 Japan Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.3 Japan Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.3.8.4 Japan Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.3.9 India: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.1 India: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.2 India Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.3 India Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.3.9.4 India Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.3.10 South Korea: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.1 South Korea: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.2 South Korea Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.3 South Korea Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.3.10.4 South Korea Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.3.11 Australia: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.1 Australia: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.2 Australia Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.3 Australia Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.3.11.4 Australia Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • 10.4 Middle East & Africa: Wearable Injectors Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Wearable Injectors Market - Revenue and Forecast to 2027 (US$ Million)
    • 10.4.3 Middle East & Africa Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.4.4 Middle East & Africa Wearable Injectors Market, by Application- Revenue and Forecast to 2027 (USD Million)
    • 10.4.5 Middle East & Africa Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.4.6 Middle East & Africa: Wearable Injectors Market, by Country, 2018 & 2027 (%)
    • 10.4.7 UAE: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.1 UAE: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.2 UAE Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.3 UAE Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.4.7.4 UAE Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.4.8 Saudi Arabia: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.1 Saudi Arabia: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.2 Saudi Arabia Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.3 Saudi Arabia Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.4.8.4 Saudi Arabia Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.4.9 South Africa: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.1 South Africa: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.2 South Africa Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.3 South Africa Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.4.9.4 South Africa Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • 10.5 South and Central America: Wearable Injectors Market
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
    • 10.5.3 South and Central America Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.5.4 South and Central America Wearable Injectors Market, by Application- Revenue and Forecast to 2027 (USD Million)
    • 10.5.5 South and Central America Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.5.6 South and Central America: Wearable Injectors Market, by Country, 2019 & 2027 (%)
    • 10.5.7 Brazil: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.1 Brazil: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.2 Brazil Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.3 Brazil Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.5.7.4 Brazil Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.5.8 Argentina: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.1 Argentina: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.2 Argentina Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.3 Argentina Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
      • 10.5.8.4 Argentina Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)

11. Impact Of COVID-19 Pandemic on Global Wearable Injectors Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment Of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Wearable Injectors Market -Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 BD
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 CeQur SA
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Debiotech S.A.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 E3D Elcam Drug Delivery Devices
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Insulet Corporation
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Gerresheimer AG
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Tandem Diabetes Care Inc.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Zealand Pharma A/S
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 West Pharmaceutical Services, Inc.
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Ypsomed AG
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Medtronic
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Amgen, Inc.
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments

14. Appendix

  • 14.1 About the Insight Partners
  • 14.2 Glossary of Terms
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.